OMERS Administration Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Sell |
3,840
-500
| -12% | -$263K | 0.02% | 374 |
|
|
2025
Q1 | $2.75M | Sell |
4,340
-639
| -13% | -$405K | 0.02% | 274 |
|
|
2024
Q4 | $3.55M | Sell |
4,979
-1,563
| -24% | -$1.11M | 0.03% | 205 |
|
|
2024
Q3 | $6.88M | Buy |
6,542
+800
| +14% | +$841K | 0.06% | 134 |
|
|
2024
Q2 | $6.04M | Buy |
+5,742
| New | +$6.04M | 0.06% | 142 |
|
|
2020
Q1 | – | Sell |
-16,000
| Closed | -$6.01M | – | 346 |
|
|
2019
Q4 | $6.01M | Sell |
16,000
-15,400
| -49% | -$5.78M | 0.07% | 165 |
|
|
2019
Q3 | $8.71M | Buy |
+31,400
| New | +$8.71M | 0.09% | 130 |
|